CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | Cumbo Alexander President and CEO | Sale 10b5-1 | −16,644 | $5.82 | $97K | 235,405 |
| 2026-02-18 | Hanrahan Jessie Chief Regulatory Officer | Sale 10b5-1 | −4,134 | $5.82 | $24K | 74,318 |
| 2026-02-18 | Ganot Ilan Director | Sale 10b5-1 | −2,658 | $5.82 | $15K | 27,474 |
| 2026-02-18 | Herzich Paul Chief Technology Officer | Sale 10b5-1 | −3,616 | $5.82 | $21K | 72,638 |
| 2026-02-18 | Howton David T Chief Operating Officer | Sale 10b5-1 | −7,469 | $5.82 | $43K | 105,077 |
| 2026-02-18 | Brooks Gabriel Chief Medical Officer | Sale 10b5-1 | −0 | $5.82 | $0 | 89,466 |
| 2026-02-18 | Tan Kevin CFO & Treasurer | Sale 10b5-1 | −5,404 | $5.82 | $31K | 99,422 |
| 2026-02-13 | Cumbo Alexander President and CEO | Option exercise 10b5-1 | +30,031 | 252,049 | ||
| 2026-02-13 | Cumbo Alexander President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −30,031 | 60,063 | ||
| 2026-02-13 | Hanrahan Jessie Chief Regulatory Officer | Option exercise 10b5-1 | +8,125 | 78,452 | ||
| 2026-02-13 | Hanrahan Jessie Chief Regulatory Officer | Option exercise · Restricted Stock Units 10b5-1 | −8,125 | 16,250 | ||
| 2026-02-13 | Ganot Ilan Director | Option exercise 10b5-1 | +4,861 | 30,132 | ||
| 2026-02-13 | Ganot Ilan Director | Option exercise · Restricted Stock Units 10b5-1 | −4,861 | 9,722 | ||
| 2026-02-13 | Herzich Paul Chief Technology Officer | Option exercise 10b5-1 | +7,187 | 76,254 | ||
| 2026-02-13 | Herzich Paul Chief Technology Officer | Option exercise · Restricted Stock Units 10b5-1 | −7,187 | 14,376 | ||
| 2026-02-13 | Howton David T Chief Operating Officer | Option exercise 10b5-1 | +14,687 | 112,546 | ||
| 2026-02-13 | Howton David T Chief Operating Officer | Option exercise · Restricted Stock Units 10b5-1 | −14,687 | 29,376 | ||
| 2026-02-13 | Brooks Gabriel Chief Medical Officer | Option exercise 10b5-1 | +10,937 | 95,029 | ||
| 2026-02-13 | Brooks Gabriel Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | −10,937 | 21,876 | ||
| 2026-02-13 | Tan Kevin CFO & Treasurer | Option exercise 10b5-1 | +10,625 | 104,826 |
Page 2 of 12 · 223 trades